167 related articles for article (PubMed ID: 38322566)
1. Long-term prognostic importance of high levels of sST2 in patient with AMI: a meta-analysis.
Ji H; Yuan L; Jiang W; Chen J
Am J Transl Res; 2024; 16(1):1-11. PubMed ID: 38322566
[TBL] [Abstract][Full Text] [Related]
2. The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
Liu N; Hang T; Gao X; Yang W; Kong W; Lou Q; Yang J
PLoS One; 2020; 15(9):e0238775. PubMed ID: 32886697
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 for Prediction of Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Receiving Primary PCI.
Liu X; Hu Y; Huang W; Zhang G; Cao S; Yan X; Li L; Zhang L; Zheng X
Int Heart J; 2019 Jan; 60(1):19-26. PubMed ID: 30464124
[TBL] [Abstract][Full Text] [Related]
4. Role of Soluble ST2 Levels and Beta-Blockers Dosage on Cardiovascular Events of Patients with Unselected ST-Segment Elevation Myocardial Infarction.
Huang WP; Zheng X; He L; Su X; Liu CW; Wu MX
Chin Med J (Engl); 2018 Jun; 131(11):1282-1288. PubMed ID: 29786039
[TBL] [Abstract][Full Text] [Related]
5. Prognostic nutritional index during hospitalization correlates with adverse outcomes in elderly patients with acute myocardial infarction: a single-center retrospective cohort study.
Li M; Cai J; Jiang K; Li Y; Li S; Wang Q; Liu H; Qu X; Kong C; Shi K
Aging Clin Exp Res; 2024 Mar; 36(1):56. PubMed ID: 38441718
[TBL] [Abstract][Full Text] [Related]
6. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention.
Zhang Q; Hu M; Ma S
J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance for major adverse cardiac events of soluble suppression of tumorigenicity 2 levels in patients with ST-segment elevation myocardial infarction.
Kim M; Lee DI; Lee JH; Kim SM; Lee SY; Hwang KK; Kim DW; Cho MC; Bae JW
Cardiol J; 2021; 28(2):244-254. PubMed ID: 32104902
[TBL] [Abstract][Full Text] [Related]
8. In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French registry on Acute ST-elevation or non-ST-elevation myocardial infarction (FAST-MI) 2005 cohort.
Ederhy S; Cohen A; Boccara F; Puymirat E; Aissaoui N; Elbaz M; Bonnefoy-Cudraz E; Druelles P; Andrieu S; Angoulvant D; Furber A; Ferrières J; Schiele F; Cottin Y; Simon T; Danchin N;
Arch Cardiovasc Dis; 2019 Nov; 112(11):657-669. PubMed ID: 31761740
[TBL] [Abstract][Full Text] [Related]
9. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
10. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in soluble suppression of tumorigenicity 2 levels predict major adverse cardiovascular events in patients with ST‑segment elevation myocardial infarction.
Liu L; Li S; Ding X; Wang D; Li W; Li H
Pol Arch Intern Med; 2022 Oct; 132(10):. PubMed ID: 35984957
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
PeerJ; 2020; 8():e9068. PubMed ID: 32355581
[TBL] [Abstract][Full Text] [Related]
13. Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.
Gu L; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31092701
[No Abstract] [Full Text] [Related]
14. Impact of Acute Myocardial Infarction Type on Prognosis in Female Patients With Cardiogenic Shock.
Jeon BK; Jang WJ; Park IH; Oh JH; Yang JH; Gwon HC; Ahn CM; Yu CW; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD
Am J Cardiol; 2023 Nov; 206():116-124. PubMed ID: 37690149
[TBL] [Abstract][Full Text] [Related]
15. Association between N-terminal pro-BNP and 12 months major adverse cardiac events among patients admitted with NSTEMI.
Gong X; Zhang T; Feng S; Song D; Chen Y; Yao T; Han P; Liu Y; Li C; Song Z; Gao J; Cui Z; Ma J; Liu Y
Ann Palliat Med; 2021 May; 10(5):5231-5243. PubMed ID: 34044561
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of patients with cardiogenic shock following acute myocardial infarction: The difference between ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction.
Tsai ML; Hsieh MJ; Chen CC; Wu VC; Lan WC; Huang YT; Hsieh IC; Chang SH
Medicine (Baltimore); 2022 Sep; 101(36):e30426. PubMed ID: 36086759
[TBL] [Abstract][Full Text] [Related]
17. Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical reperfusion therapy.
Mechtouff L; Paccalet A; Crola Da Silva C; Buisson M; Mewton N; Amaz C; Bonnefoy-Cudraz E; Leboube S; Cho TH; Nighoghossian N; Ovize M; Bochaton T
J Neurol; 2022 May; 269(5):2641-2648. PubMed ID: 34694426
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Impact of Acute Myocardial Infarction in Patients Presenting With Ventricular Tachyarrhythmias and Aborted Cardiac Arrest.
Behnes M; Mashayekhi K; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Schupp T; Ansari U; El-Battrawy I; Rusnak J; Akin M; Borggrefe M; Akin I
J Am Heart Assoc; 2018 Oct; 7(19):e010004. PubMed ID: 30371335
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymphocyte to C-reactive protein ratio: A new prognostic indicator of post-primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Liu Y; Ye T; Chen L; Xu B; Wu G; Zong G
Int Immunopharmacol; 2023 Jan; 114():109594. PubMed ID: 36525793
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
